This study delivered one of the first large-scale molecular characterizations of angiosarcoma and was shaped and enabled by the angiosarcoma patient community, including members of the Angiosarcoma Cancer Facebook group who helped design and participated in the work.
This resource includes clinical and molecular data from 274 angiosarcoma patients. Researchers use this dataset to explore disease heterogeneity, generate therapeutic hypotheses, study tumor evolution, and develop computational or translational methods. The data are openly available and intended for broad reuse.
We favor work that produces shared resources or openly available data (e.g. cell models, PDX models, datasets), but we are open to any ideas with potential for outsized impact for patients with angiosarcoma.
Researchers interested in funding should contact us.
